Aryeh Jason

SEC Form 4 insider

LIGAND PHARMACEUTICALS INC ($LGND)

2 theses · first seen Nov 4, 2026

Window	Theses	Resolved	Wins	Win rate	Avg return	Median return
1d	2	2	1	50%	-0.8%	-0.8%
3d	1	1	1	100%	-2.3%	-2.3%
1w	1	1	0	0%	+0.2%	+0.2%
1m	0	0	0	—	—	—
3m	0	0	0	—	—	—
6m	0	0	0	—	—	—
1y	0	0	0	—	—	—

Past performance does not predict future results. Informational only, not investment advice.

Thesis history

$LGNDSEC Form 4bearish

Aryeh Jason · LIGAND PHARMACEUTICALS INC · 2d ago1 prior · awaiting results

Sold 3,000 @ $320.05 avg · $960,141 · 2026-11-10

Form 4: Aryeh Jason sold LGND

Aryeh Jason (Director at LIGAND PHARMACEUTICALS INC) reported an open-market sale of 3,000 shares of LGND at an average $320.05, roughly $960,141, in a Form 4 filed 2026-11-12.

At post $316.27Now $308.79-2.4% since postedas of Nov 13, 4:01 PM ET

1d-2.4%

3d—

1w—

1m—

3m—

6m—

1y—

View filing on SEC.gov →

$LGNDSEC Form 4bearish

Aryeh Jason · LIGAND PHARMACEUTICALS INC · 11d ago1 prior · awaiting results

Sold 2,111 @ $320.30 avg · $676,158 · 2026-10-30

Form 4: Aryeh Jason sold LGND

Aryeh Jason (Director at LIGAND PHARMACEUTICALS INC) reported an open-market sale of 2,111 shares of LGND at an average $320.30, roughly $676,158, in a Form 4 filed 2026-11-03.

At post $313.52Now $308.79-1.5% since postedas of Nov 13, 4:01 PM ET

1d+0.8%

3d-2.3%

1w+0.2%

1m—

3m—

6m—

1y—

View filing on SEC.gov →

End of results.